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Abstract
Background: Alzheimer disease (AD) is a neurodegenerative disorder for which there is no cure. We have investigated
synaptic plasticity in area CA1 in a novel AD mouse model (APPPS1-21) which expresses the Swedish mutation of APP and
the L166P mutation of human PS-1. This model shows initial plaque formation at 2 months in the neocortex and 4 months
in the hippocampus and displays b2amyloid-associated pathologies and learning impairments.
Methodology/Principal Findings: We tested long-term potentiation (LTP) and short term potentiation (paired-pulse
facilitation, PPF) of synaptic transmission in vivo in area CA1 of the hippocampus. There was no difference in LTP or PPF at
4–5 months of age in APPPS1-21 mice compared to littermate controls. At 6 months of age there was also no difference in
LTP but APPPS1-21 mice showed slightly increased PPF (p,0.03). In 8 months old mice, LTP was greatly impaired in APPPS-
21 animals (p,0.0001) while PPF was not changed. At 15 months of age, APPPS1-21 mice showed again impaired LTP
compared to littermate controls (p,0.005), and PPF was also significantly reduced at 80 ms (p,0.005) and 160 ms (p,0.01)
interstimulus interval. Immunohistological analysis showed only modest amyloid deposition in the hippocampus at 4 and 6
months with a robust increase up to 15 months of age.
Conclusions: Our results suggest that increased formation and aggregation of beta amyloid with aging is responsible for
the impaired LTP with aging in this mouse model, while the transient increase of PPF at 6 months of age is caused by some
other mechanism.
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Introduction
Alzheimer disease (AD) is a neurodegenerative disorder for
which there is no cure. Two of the hallmarks are the accumulation
of b-amyloid plaques and of tau tangles [1,2]. APPPS1-21 mice
are a recently generated transgenic mouse model on a C57BL/6J
genetic background that co-expresses the KM670/671NL mutat-
ed human amyloid precursor protein and the L166P mutated
human presenilin 1 (APPPS1-21 mice) and model aspects of
cerebral amyloidosis. Plaque formation starts after 2 months in the
neocortex and 4 months in the hippocampus, and the ratio of b-
amyloid42 to b-amyloid40 is 1.5 in young and 5 in amyloid-
depositing older mice, respectively. Consistent with this ratio,
extensive congophilic parenchymal amyloid but minimal amyloid
angiopathy is observed [3,4]. Amyloid-associated pathologies
include dystrophic synaptic boutons, hyperphosphorylated tau-
positive neuritic structures and robust gliosis and microglia
numbers. Global neocortical neuron loss is not apparent in this
mouse model, but local neuronal loss in the dentate gyrus is
observed at 17 months of age (Rupp et al., 2009). Furthermore,
spatial memory deficits in a plus maze task is apparent at the age of
8 months [3]. These findings suggest that the overproduction of b-
amyloid, the formation of plaques and the subsequent inflamma-
tion response is sufficient to produce a series of symptoms that are
consistent with those observed in patients with AD.
In this study, we have investigated synaptic plasticity in
APPPS1-21 mice. Synaptic plasticity is a form of rapid upregula-
tion of neurotransmission after repetitive stimulation of axonal
projections that is considered to be related to the cellular changes
that underlie memory formation [5,6]. The accumulation of
plaques, the development of the inflammation response, and the
impairment in memory formation would suggest that synaptic
activity will be affected. However, studies of mouse models of AD
that also overexpress human mutated APP show mixed results. A
mouse model that expresses the KM670/671NL human mutated
APP showed no impairment in LTP in area CA1 up to 24 months
of age [7]. In contrast, a mouse model that expresses the Swedish
APP K595N, M596L double mutation showed impaired LTP in
the dentate gyrus and the area CA1 in 15–17 months old mice [8].
Another mouse model carrying the Swedish mutated human APP
and the PS1 (A246E) transgenes showed that LTP in vitro in area
CA1 was unaffected, and in vivo LTP the dentate gyrus was only
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expresses the Swedish APP and the PS1 delta E9 transgenes, in vitro
LTP in area CA1 was hardly affected at all [10]. These findings
underscore the differences between different transgenic constructs,
and show that the formation of b-amyloid plaques is no guarantee
that synaptic impairments develop in the brains of tg mice. We
therefore set out to investigate if short-term potentiation (paired-
pulse facilitation) or long-term potentiation of synaptic transmis-
sion in area CA1 in vivo is affected in the APPPS1-21 mice and
correlated that with beta-amyloid plaque load in the hippocampus.
Materials and Methods
Animals
APPPS1-21 mice with a C57/Bl6 background were obtained
from Prof. M. Jucker and bred at the Ulster University animal unit.
Heterozygous males APPPS1 mice were bred with wild-type C57/
Bl6 females bought locally (Harlan, UK). Offspring was tail snipped
and genotyped using PCR with primers specific for the APP-
sequence (Forward:‘‘GAATTCCGACATGACTCAGG’’, Reverse:
‘‘GTTCTGCTGCATCTTGGACA’’). Positive heterozygous ani-
mals and negative wild type littermate controls were used for the
experiments. After the end of the experiments, the PCR results were
confirmed by histology using Congo-red stain (see below).
All experiments were licensed by the UK home office in
according to the animal (scientific procedures) Act of 1986.
Surgery and LTP recording in the hippocampus area CA1
Mice were anaesthetised with urethane (ethyl carbamate, 1.8 g/
kg, i.p.) for the duration of all experiments. The skull was exposed
and 3 holes with 0.8 mm diameter were drilled. Electrodes
(tungsten with Teflon coating, Bilaney, Kent, UK) were implanted
in the following coordinates: 1.5 mm posterior and 1.0 mm lateral
to the midline for the recording electrode, and the stimulating
electrode 2.0 mm posterior to bregma and 1.5 mm lateral to the
midline. The earth electrode location was at 3.0 mm posterior to
bregma and 2.5 mm lateral to the midline, contralateral to the
electrode sites. The electrodes were slowly lowered through the
cortex and the upper layers of the hippocampus and into the CA1
region (approx. 1.2 mm) until the appearance of a negative
deflecting excitatory postsynaptic potential (EPSP) that had a
latency of ca. 10 ms. Recordings of field excitatory postsynaptic
potentials (fEPSPs) were made from the stratum radiatum in the
CA1 region of the right hippocampal hemisphere in response to
stimulation of the Schaffer collateral/commissural pathway.
fEPSPs were recorded on a computerised stimulating and
recording unit (PowerLab, ADI instruments) in which the trigger
threshold was adjustable. The triggered unit activated a constant
current stimulus isolation unit (Neurolog, UK). The data
acquisition system was triggered simultaneously to record all
events. Sampling speed was at 20 kHz for recordings of fEPSPs.
The high frequency stimulation protocol for inducing LTP
consisted of 1 train of 100 stimuli, inter-stimulus interval 5 ms
(200 Hz). This rather weak LTP induction protocol was chosen to
prevent saturation of the LTP and thus allow the possibility to
detect improvements as well as impairments of the LTP in the
APPPS1-21 mice. Stimulation intensity was 60% of the max.
fEPSP, as analysed by establishing an input-output correlation.
LTP was measured as % of baseline fEPSP slope recorded over a
15 min period prior to application of high frequency stimulation.
This value was taken as 100% of the EPSP slope and all recorded
values were normalised to this baseline value. Basic synaptic
transmission was tested by stimulating with a range of intensities.
Paired-pulse facilitation (PPF) was measured to analyse pre-
synaptic functions and interneuron activity. Two stimuli were
given at 60% of max fEPSP response. The interval between two
Figure 1. Input-output correlation in different age groups of APPPS1-21 mice and their wild type littermate controls. There was no
difference found in baseline transmission at any age group (2-way repeated measure ANOVA, p.0.05).
doi:10.1371/journal.pone.0009764.g001
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analyse PPF in relation to time. The PPF induced at short
interstimulus intervals is considered to be triggered by pre-synaptic
transmitter release facilitating processes [11], while later PPF is
considered to be linked to GABAa and GABAb interneuronal
synaptic transmission [12,13]. The size of the fEPSP response was
measured by analysing the change from baseline to the lowest
point of the fEPSP. Data were normalised by taking the first fEPSP
value as 100% and comparing the second fEPSP with it.
Histology
After the LTP studies, animals were perfused transcardially with
PBS buffer followed by ice-cold 4% paraformaldehyde in PBS.
Brains were removed and fixed in 4% paraformaldehyde in PBS.
Brains were left in a 30% sucrose solution until they had sunk to
the bottom of the container. Brains were shock frozen and cut at
40 mm on a Leica cryostat. For stereological analysis, the first
section was taken at random and every 5
th section taken
afterwards. Sections were analysed using the optical fractionator
technique with twodimensional disectors (microglia), as described
previously [14,15]. Sections were stained for plaques by a rabbit
anti-Amyloid beta-Peptide polyclonal antibody (1:250, Invitrogen,
UK, 71-5800), using the protocols published in [3].
Prior to staining, slices were incubated in 99% formic acid for 7
minutes for antigen retrieval; this procedure is known to enhance
antibody recognition of Amyloid beta [16]. For the stereological
analysis, photographs of the hippocampus of each section were
taken on an Olympus CX 40 microscope using the 10x
magnification lens (=25 x magnification) and a computer
controlled digital 5.1 MegaPix camera. Averages of all section
Figure 2. Inducing LTP in area CA1 in APPPS1-21 mice or littermate wild type controls aged 4.5 months showed robust LTP that
lasted for 1 h post-HFS (n=8 per group). A 2-way repeated measures ANOVA did not show a difference between genotypes but over time
(p,0.0001). Below: Shown are typical field fEPSPs of recordings 5 min before (1) and 1 h after HFS (2).
doi:10.1371/journal.pone.0009764.g002
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better demonstration of the anatomy of the hippocampus, a
standard background Hematoxylin and Eosin staining [17] was
performed in some sections.
Statistics
All data were analysed using the program Prism (Graphpad
software Inc., USA).
LTP data were analyzed with 2-way repeated measure mixed
model ANOVA with genotype as the between subject factor and
time as the within-subject factor. The LTP data were analyzed for
the whole 60 minutes recorded after HFS, as well as for the time
sections of 1–30, 31–60, 1–20, 21–40 and 41–60 minutes after HFS.
PPF data of APPPS1-21 and controllittermates were analysed using
a 1-way ANOVA and a post hoc Yuen’s test [18,19] for every
interstimulus interval. Data were log-transformed if the data
variation of the tg and wt groups was different between groups.
Results
Basic synaptic transmission - input output correlations
The basic synaptic response of different age groups of APPPS1-
21 and their wild type littermates were compared. At no age group
there was a difference between groups in two-way repeated-
measure ANOVAs. In all groups, fEPSPs increased in correlation
with stimulus increase. 4.5 months age group: Genotype:
F1,56=0.004; p.0.05; stimulus intensity: F4,56=59.69;
p,0.0001. 6 months: Genotype: F1,64=0.057; p.0.05; stimulus
intensity: F4,64=31.16; p,0.0001. 8 months: Genotype:
F1,64=0.11; p.0.05; stimulus intensity: F4,64=66.3; p,0.0001.
15 months age group: Genotype: F1,56=0.003; p.0.05; stimulus
intensity: F4,56=24.15; p,0.0001 (see fig. 1).
LTP in 4.5 months old animals
In 4–5 months old animals, HFS stimulation of the Schaffer
collaterals induced robust LTP in both groups. A 2-way repeated
measures mixed model ANOVA did not find a difference between
groups (genotype) but over time (F119,1309 =1.849, P,0.0001),
showing a decay in LTP in both groups. The interaction between
the factors was not significant (n=8 per group) (fig. 2). The paired-
pulse facilitation study showed good paired-pulse facilitation at all
interstimulus intervals tested (25, 50, 80, 120, 160, 200 ms). A 1-
way ANOVA did not find any overall difference, and neither
Yuen’s post hoc test showed differences between genotypes for
PPF at any interstimulus interval (see fig. 3).
6 months old animals
HFS induced good LTP in both groups (n=9 per group). There
was a trend for the APPPS1-21 group to show stronger LTP. A 2-
way repeated measures ANOVA did not find a difference between
genotypes nor over time, but the interaction between the two
factors was significant in the LTP consolidation phase (minutes
40–60 post-HFS; F39,429=1.54, p,0.02), showing that the effect
that time had on the development of LTP was dependent on the
genotype (see fig. 4). The paired-pulse facilitation study showed
good facilitation at all interstimulus intervals tested (25, 50, 80,
120, 160, 200 ms). A 1-way repeated measures ANOVA showed a
difference between groups (F11,1309=2.5, p,0.01). APPPS1-21
animals had stronger PPF than littermate controls at the 160 ms
interstimulus interval, Yuen’s post-hoc test showed a difference
between groups (t10 =2.53, p,0.03) (see fig. 5).
8 months old animals
In 8 months old animals, HFS stimulation of the Schaffer
collaterals induced robust LTP in both groups. A 2-way repeated
measures mixed model ANOVA did not find a difference between
groups (genotype) but found a difference over time (F119, 1428=4.9
p,0.0001), showing that there was a decay in LTP in both groups.
The interaction between the factors was not significant (n=13 per
group) (fig. 6). The paired-pulse facilitation study showed good
facilitation at all interstimulus intervals tested (25, 50, 80, 120, 160,
200 ms). A 1-way repeated measures ANOVA showed a difference
between groups (F11=2.8, p=0.003). However, a post hoc Yuen’s
tests did not show differences between genotypes for PPF at any
interstimulus interval (see fig. 7).
15 months old animals
In 15 months old animals, HFS did not induce LTP in the
APPPS1-21 animals. APPPS1-21 mice showed no LTP at 60 min
post-HFS (94+/24% SEM of baseline), while controls still showed
stable LTP (126+/27%). A 2-way repeated measures mixed model
ANOVA find a difference between genotypes after log transforma-
tion (F119,833=4.837, p,0.05) and a difference over time
(F119,823=7.517, p,0.0001), showing that there was a decay in
LTP in both groups. There was no interaction between the factors
(n=8 per group). When separating the 60 min post- HFS recordings
into the LTP induction phase (1–20 min), a transition phase (21–
40 min) and the consolidation phase (41–60 min), it was found in the
induction phase that there was no difference between genotypes, but
again a difference over time (F39,273=3.311, p,0.0001). In the
transition phase (21–40 min) of LTP, there was a significant
Figure 3. Paired-pulse facilitation in area CA1 in 4.5 moths old
animals. The interstimulus interval was set at 25–200 ms. Analysis by
1-way ANOVA did not find an overall difference. A sample trace is
shown which demonstrates paired-pulse facilitation at 80 ms interstim-
ulus interval.
doi:10.1371/journal.pone.0009764.g003
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genotype and time (F39,273=1.683, p=0.007). A similar result was
found in the consolidation phase (41–60 min) of LTP, there was a
significant difference between groups (F1,273=4.74, p,0.05) and also
over time (F39,273=2.25, p,0.0001), showing that APPPS1-21
animals had reduced LTP compared to controls. The interaction
between the factors was not significant (fig. 8).
A 1-way repeated measures ANOVA showed a difference
between groups (F11=2.3, p,0.05). APPPS1-21 animals showed
impaired PPF compared with littermate controls at 80 ms and
160 ms interstimulus interval as shown in post-hoc tests: At the
interstimulus interval 80 ms, Yuen’s test (t6.17=3.696, p,0.01)
showed a highly significant difference between genotypes, and at
the interstimulus interval 160 ms Yuen’s test (t5.65=3.02, p,0.03)
discovered a significant impairment of PPF in the APPPS1-21
mice as well (fig. 9).
Histology
Staining the beta-amyloid plaque load in the hippocampus
showed a progressive increase of numbers in the APPPS1-21 mice.
Controls showed no plaque staining. A one-way ANOVA revealed
anoveralldifferencebetweengroupsF=104,p,0.0001(seefig.10).
Figure 4. Inducing LTP in area CA1 in APPPS1-21 mice or littermate wild type controls aged 6 months showed robust LTP (n=9 per
group). A 2-way repeated measures ANOVA did not find a difference between genotypes. Below: Shown are typical field fEPSPs of recordings 5 min
before (left) and 1 h after HFS (right).
doi:10.1371/journal.pone.0009764.g004
Figure 5. Paired-pulse facilitation in area CA1 in 6 months old
animals. The interstimulus interval was set at 25–200 ms. A 1-way
repeated measures ANOVA showed a difference between groups
(p,0.01). The 160 ms interstimulus interval showed a difference
between groups (p,0.03) in a post-hoc Yuen’s test, demonstrating
increased PPF in the APPPS1-21 group.
doi:10.1371/journal.pone.0009764.g005
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The results presented here show that an expression of mutated
human APP and PS-1 that produced b-amyloid1-42 and b-
amyloid1-40 levels, plaque formation from 2–3 months onwards
with the associated inflammatory response, and memory impair-
ments from 8 months onwards [3] has distinct effects on synaptic
plasticity in area CA1 of the hippocampus. In younger animals up
to 5 months of age, no detrimental effects on synaptic plasticity
were found. At this stage, b-amyloid production, plaque formation
and the associated inflammation responses in the brain is still on a
relatively low level. Significant amounts of plaques in the
hippocampus were only observed from 6–8 months onwards,
which is much delayed compared to the cortex. We previously
observed that plaques in the cortex appear from 2 months
onwards with a rapid increase in numbers, while the hippocampus
showed a much delayed onset of amyloid deposition. In area CA1
of the hippocampus, increased plaque numbers did not appear
until 8 months of age (see Radde et al. 2006 for examples of plaque
deposition in the hippocampus and cortex), a finding that we
confirmed in the present study. The relatively late impairment of
CA1 LTP that we observed in the present study could be related to
this delayed formation of plaques in the hippocampus. At 8
months of age, plaque formation had reached a comparatively
Figure 6. Inducing LTP in area CA1 in APPPS1-21 mice or littermate wild type controls aged 8 months showed robust LTP that lasted
for 1 h post-HFS (n=12 per group). A 2-way repeated measures ANOVA showed a difference between genotype (p,0.001) over time (p,0.0001),
showing that there was a decay of LTP in both groups. Below: Shown are typical field fEPSPs of recordings 5 min before (left) and 1 h after HFS (right).
doi:10.1371/journal.pone.0009764.g006
Figure 7. Paired-pulse facilitation in area CA1 in 8 months old
animals. A 1-way repeated measures ANOVA showed a difference
between groups (p,0.005), but post hoc tests showed no differences
between genotypes at any interstimulus interval.
doi:10.1371/journal.pone.0009764.g007
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learning and LTP.
The central finding in this study is that LTP was completely
obliterated in 8 and 15 month old APPPS1-21, while age matched
wild type littermate controls still showed good LTP. This
impairment of LTP can be due to several processes. At the 8
month time point, the learning ability of these mice is also severely
compromised [3]. Other studies have shown that the APPPS1-21
mouse model has decreased numbers of synapses and also shows
abnormal neuritic anatomy and regional neuronal loss when aged
(Rupp et al., 2009), and a decrease in synapse numbers and vesicle
release [20]. These processes will have detrimental effects on
synaptic plasticity. Additionally, the inflammation response
observed in these mice (Radde et al., 2009) will have further
detrimental effects on synaptic plasticity through the release of
proteolytic enzymes and the formation of reactive oxygen species
[21].
While this strong impairment is to be expected, it does not
explain why some mouse models that overexpress mutated APP
and develop high numbers of plaques show no or very little
impairment in synaptic plasticity [7,9,22]. There are several
possible reasons for these differences. One LTP study that used the
APP23 mice which also express the same Swedish APP mutation
as the APPPS1-21 mice did not show any impairment in LTP.
Somewhat surprisingly, the authors found a difference in basal
Figure 8. In 15 months old animals, HFS did not induce LTP in the APPPS1-21 animals (n=8 per group). There was a difference between
genotypes (p,0.01) and a difference over time (p,0.0001). There was no interaction between these factors.
doi:10.1371/journal.pone.0009764.g008
Figure 9. Paired-pulse facilitation in area CA1 in 15 months old
animals. APPPS1-21 mice were severely impaired in PPF. A 1-way repeated
measures ANOVA showed a difference between groups (p,0.05). Yuen’s
post-hoc tests showed highly significant differences between genotypes at
80 ms (p,0.01) and 160 ms (p,0.01) interstimulus interval.
doi:10.1371/journal.pone.0009764.g009
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LTP even in aged 24 months old APP 23 mice (Roder et al., 2003).
The study shows that a difference in baseline response does not
necessarily translate into a difference in LTP. An important
difference in the two mouse models is the amount of beta-amyloid
and plaque load. The reason why the mutated PS1 had been
added to the mutated APP gene was that plaque formation is very
much accelerated by this. Plaques start to appear in the APPPS1-
21 model at 2 months of age and numbers rapidly increase [3],
while in the APP23 mouse model, plaques start to appear at 6
months of age [23]. The different genetic background also can
have a large effect on physiological processes, since different
mouse strains show different sensitivities to neurodegenerative
influences (see [24] for a discussion of genetic background effects).
In addition, there is evidence that not just the plaques themselves,
but also soluble oligomers of b-amyloid have detrimental effects on
synaptic transmission and neuronal survival. Different transgenic
strains differ in the levels of production of amyoid oligomer species
that have been shown to impair neuronal activity and synaptic
plasticity [25]. Interestingly enough, there is also an increased risk
for epilepsy in patients with dementia, making it likely that these
compensatory processes are also found in human brains [26,27].
These compensatory mechanisms, which are most likely controlled
by a negative feedback system that keeps overall neuronal activity
at physiological levels, could explain why some mouse models
show remarkably few functional impairments and symptoms even
with large plaque loads in the cortex. Consistent with these
observations, imaging studies of Alzheimer patients and age
matched controls showed no clear correlation between plaque load
and cognitive impairment [28], indicating that there is a large
Figure 10. Analysis of the plaque load shows an age-dependent increase of plaque numbers in the hippocampus of APPPS1 mice. A
one-way ANOVA showed an overall difference of p,0.0001. Scale bar =500 mm. Lower right: a sample micrograph of an electrode location in area
CA1, strat. radiatum (= rad); pyr = strat. pyramidale, or = strat. oriens, DG = dentate gyrus.
doi:10.1371/journal.pone.0009764.g010
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associated gliosis, synaptic and neuronal loss, and other detrimen-
tal influences on brain activity. The mouse model analysed in this
study not only has a mutated form of human APP, but also a
mutated form of PS-1. PS-1 is involved in the cleavage of several
cell signalling molecules, and an impairment of its function has
effects on synaptic growth and vesicle release. In hippocampal
cultures from APPPS1-21 mice, the size of the readily releasable
synaptic vesicle pool was decreased, while in a single-mutant APP
transgenic model (APP23, APPswe), this effect was not observed
(Priller, 2009). Others have shown that in mice that express
mutated PS-1, synaptic plasticity can be impaired [29]. However,
in a different study that investigated PS-1 KO mice, little effect on
LTP was found, while a APP(V717I) mutation mouse strain
showed much impaired LTP. Deleting PS-1 in the APP(V717I)
mice actually rescued LTP in these mice [30]. In a more recent
study, mice that expressed mutant [A246E]PS-1 also showed
healthy LTP which was even increased compared to controls [31].
These results suggest that the main effect observed in the LTP
studies shown here are due to the overexpression and aggregation
of mutated human APP, though a small contribution by the PS-1
mutation to this impairment cannot be ruled out.
At 6 months of age, somewhat surprisingly, a slight facilitation
of PPF was observed in the APPPS1-21 animals. This finding is
unexpected but may be explained as a form of compensation for
synaptic impairment. Neuronal networks in the brain can
compensate for impairments by upregulating excitatory or
downregulating inhibitory neuronal activity. A study of APP-
overexpressing mice strain (PDAPP mice) showed that in aged
transgenic mice, baseline field potentials in the hippocampus often
failed, while synaptic plasticity and LTP was often enhanced. The
authors interpret the enhancement as a compensatory mechanism
to counter-balance disturbances in synaptic transmission that
appear when abundant plaques and Alzheimer’s-like neuropa-
thology are present, and which explains why such synaptic
impairments are not necessarily accompanied by a disproportion-
ate loss of LTP [22]. A different study has shown that GABAergic
inhibition is altered in a APP/PS-1 mouse model of AD, showing
that not only excitatory but also inhibitory activity is altered [32].
Therefore, it is possible that the increased PPF in the APPPS1-21
mice could be due to changed local GABA inhibition to
compensate for a reduction in excitatory synaptic activity. The
facilitatory effect of APP on PPF is lost at later stages of
development in APPPS1-21 mice. PPF was not different in the 8
month old group compared with age matched littermate controls.
At 15 months of age, a clear decrease of PPF was found in
APPPS1-21 mice. The changes in PPF at the 160 ms interstimulus
interval time point shown in our study also suggests that local
inhibition of excitatory neuronal activity by GABAergic interneu-
rons may be changed. It has been shown that PPF at the time
window of around 160 ms is dependent on GABAb receptor
activity, which are located on synapses of interneurons [13,33].
However, further research using in vitro slices would need to
confirm any changes in the GABAergic synaptic transmission in
this mouse model, though one has to keep in mind that the
spontaneous activity of neurons in vitro differs greatly from activity
observed in vivo. If there is such a modulation of local inhibition, it
could also explain why APP mouse models are reported to have an
increased risk for epileptic seizures, which would be expected by a
downregulation of inhibitory or an upregulation of excitatory
neuronal activity [34].
In conclusion, the observed age- dependent impairment of
synaptic plasticity in APPPS1-21 mice shows that the increasing
levels of b-amyloid and accumulation of plaques with the
associated gliosis and synaptic loss result in progressive deteriora-
tion of synaptic plasticity, which correlates with age-dependent
memory impairments in this transgenic mouse strain. The
APPPS1-21 mouse strain therefore appears to be a useful model
for the study of APP and b-amyloid overexpression-related
dysfunctions in synaptic activity and cognitive performance in
the brain that is found in AD.
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